Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2170397 | 0.90 | NPSR1 (0.40) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2258580 | 0.86 | NPSR1 (0.37) | ALDH1A1GAANPSR1HPGDKMT2A | |
| SCHEMBL2256065 | 0.86 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2254716 | 0.84 | NPSR1 (0.50) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2170796 | 0.84 | NPSR1 (0.50) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL15918560 | 0.77 | ALDH1A1 (0.36) | ALDH1A1GAAKMT2AL3MBTL1KDM4E | |
| SCHEMBL2169625 | 0.77 | ALDH1A1 (0.50) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2170802 | 0.76 | ALDH1A1 (0.52) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2170806 | 0.76 | ALDH1A1 (0.52) | ALDH1A1GAAMAPTNPSR1HPGD | |
| SCHEMBL2168671 | 0.73 | NPSR1 (0.39) | ALDH1A1MAPTNPSR1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195930-A1 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195930-A1 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | NOX3, SCN3A, OR10J3 | ALDH1A1 1408/4885GAA 4567/4885MAPT 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.